ID   WNK3_HUMAN              Reviewed;        1800 AA.
AC   Q9BYP7; B1AKG2; Q5JRC1; Q6JP76; Q8TCX6; Q9HCK6;
DT   02-FEB-2004, integrated into UniProtKB/Swiss-Prot.
DT   19-OCT-2011, sequence version 3.
DT   15-MAR-2017, entry version 148.
DE   RecName: Full=Serine/threonine-protein kinase WNK3;
DE            EC=2.7.11.1;
DE   AltName: Full=Protein kinase lysine-deficient 3;
DE   AltName: Full=Protein kinase with no lysine 3;
GN   Name=WNK3; Synonyms=KIAA1566, PRKWNK3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000312|EMBL:CAC32455.2};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), TISSUE SPECIFICITY, AND
RP   CHROMOSOMAL LOCATION.
RC   TISSUE=Brain {ECO:0000269|PubMed:11571656};
RX   PubMed=11571656; DOI=10.1038/sj.onc.1204726;
RA   Verissimo F., Jordan P.;
RT   "WNK kinases, a novel protein kinase subfamily in multi-cellular
RT   organisms.";
RL   Oncogene 20:5562-5569(2001).
RN   [2] {ECO:0000305}
RP   SEQUENCE REVISION TO N-TERMINUS.
RA   Jordan P.;
RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=15194194; DOI=10.1016/j.gene.2004.03.009;
RA   Holden S., Cox J., Raymond F.L.;
RT   "Cloning, genomic organization, alternative splicing and expression
RT   analysis of the human gene WNK3 (PRKWNK3).";
RL   Gene 335:109-119(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [5] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 431-1800 (ISOFORM 3).
RC   TISSUE=Brain {ECO:0000269|PubMed:10997877};
RX   PubMed=10997877; DOI=10.1093/dnares/7.4.271;
RA   Nagase T., Kikuno R., Nakayama M., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes.
RT   XVIII. The complete sequences of 100 new cDNA clones from brain which
RT   code for large proteins in vitro.";
RL   DNA Res. 7:273-281(2000).
RN   [6]
RP   FUNCTION, MUTAGENESIS OF ASP-294, AND TISSUE SPECIFICITY.
RX   PubMed=16275913; DOI=10.1073/pnas.0508303102;
RA   Rinehart J., Kahle K.T., de Los Heros P., Vazquez N., Meade P.,
RA   Wilson F.H., Hebert S.C., Gimenez I., Gamba G., Lifton R.P.;
RT   "WNK3 kinase is a positive regulator of NKCC2 and NCC, renal cation-
RT   Cl- cotransporters required for normal blood pressure homeostasis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:16777-16782(2005).
RN   [7]
RP   FUNCTION.
RX   PubMed=16275911; DOI=10.1073/pnas.0508307102;
RA   Kahle K.T., Rinehart J., de Los Heros P., Louvi A., Meade P.,
RA   Vazquez N., Hebert S.C., Gamba G., Gimenez I., Lifton R.P.;
RT   "WNK3 modulates transport of Cl- in and out of cells: implications for
RT   control of cell volume and neuronal excitability.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:16783-16788(2005).
RN   [8]
RP   FUNCTION.
RX   PubMed=16357011; DOI=10.1113/jphysiol.2005.102202;
RA   Leng Q., Kahle K.T., Rinehart J., MacGregor G.G., Wilson F.H.,
RA   Canessa C.M., Lifton R.P., Hebert S.C.;
RT   "WNK3, a kinase related to genes mutated in hereditary hypertension
RT   with hyperkalaemia, regulates the K+ channel ROMK1 (Kir1.1).";
RL   J. Physiol. (Lond.) 571:275-286(2006).
RN   [9]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=16501604; DOI=10.1038/sj.onc.1209449;
RA   Verissimo F., Silva E., Morris J.D., Pepperkok R., Jordan P.;
RT   "Protein kinase WNK3 increases cell survival in a caspase-3-dependent
RT   pathway.";
RL   Oncogene 25:4172-4182(2006).
RN   [10]
RP   FUNCTION, INTERACTION WITH WNK1 AND WNK4, AND ENZYME REGULATION.
RX   PubMed=17975670; DOI=10.1172/JCI32033;
RA   Yang C.L., Zhu X., Ellison D.H.;
RT   "The thiazide-sensitive Na-Cl cotransporter is regulated by a WNK
RT   kinase signaling complex.";
RL   J. Clin. Invest. 117:3403-3411(2007).
RN   [11]
RP   FUNCTION.
RX   PubMed=18768590; DOI=10.1152/ajprenal.90229.2008;
RA   Zhang W., Na T., Peng J.B.;
RT   "WNK3 positively regulates epithelial calcium channels TRPV5 and TRPV6
RT   via a kinase-dependent pathway.";
RL   Am. J. Physiol. 295:F1472-F1484(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   FUNCTION, AND ALTERNATIVE SPLICING.
RX   PubMed=19470686; DOI=10.1681/ASN.2008050542;
RA   Glover M., Zuber A.M., O'Shaughnessy K.M.;
RT   "Renal and brain isoforms of WNK3 have opposite effects on NCCT
RT   expression.";
RL   J. Am. Soc. Nephrol. 20:1314-1322(2009).
RN   [14]
RP   FUNCTION.
RX   PubMed=20525693; DOI=10.1074/jbc.M110.103432;
RA   Heise C.J., Xu B.E., Deaton S.L., Cha S.K., Cheng C.J., Earnest S.,
RA   Sengupta S., Juang Y.C., Stippec S., Xu Y., Zhao Y., Huang C.L.,
RA   Cobb M.H.;
RT   "Serum and glucocorticoid-induced kinase (SGK) 1 and the epithelial
RT   sodium channel are regulated by multiple with no lysine (WNK) family
RT   members.";
RL   J. Biol. Chem. 285:25161-25167(2010).
RN   [15]
RP   FUNCTION, ALTERNATIVE SPLICING (ISOFORM 4), AND MUTAGENESIS OF
RP   ASP-294.
RX   PubMed=21613606; DOI=10.1152/ajpcell.00070.2011;
RA   Cruz-Rangel S., Melo Z., Vazquez N., Meade P., Bobadilla N.A.,
RA   Pasantes-Morales H., Gamba G., Mercado A.;
RT   "Similar Effects of all WNK3 Variants upon SLC12 Cotransporters.";
RL   Am. J. Physiol. 301:C601-C608(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-62, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [17]
RP   UBIQUITINATION BY KLHL2.
RX   PubMed=23838290; DOI=10.1016/j.bbrc.2013.06.104;
RA   Takahashi D., Mori T., Wakabayashi M., Mori Y., Susa K., Zeniya M.,
RA   Sohara E., Rai T., Sasaki S., Uchida S.;
RT   "KLHL2 interacts with and ubiquitinates WNK kinases.";
RL   Biochem. Biophys. Res. Commun. 437:457-462(2013).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1638, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   VARIANTS [LARGE SCALE ANALYSIS] HIS-704; CYS-854; THR-998; GLU-1169;
RP   ILE-1375; PHE-1533 AND PRO-1634.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine kinase which plays an important role in
CC       the regulation of electrolyte homeostasis, cell signaling,
CC       survival and proliferation. Acts as an activator and inhibitor of
CC       sodium-coupled chloride cotransporters and potassium-coupled
CC       chloride cotransporters respectively (PubMed:16275913,
CC       PubMed:16275911, PubMed:16357011). Phosphorylates WNK4. Regulates
CC       the phosphorylation of SLC12A1 and SLC12A2. Increases Ca(2+)
CC       influx mediated by TRPV5 and TRPV6 by enhancing their membrane
CC       expression level via a kinase-dependent pathway (PubMed:18768590).
CC       Inhibits the activity of KCNJ1 by decreasing its expression at the
CC       cell membrane in a non-catalytic manner.
CC       {ECO:0000269|PubMed:16275911, ECO:0000269|PubMed:16275913,
CC       ECO:0000269|PubMed:16357011, ECO:0000269|PubMed:16501604,
CC       ECO:0000269|PubMed:17975670, ECO:0000269|PubMed:18768590,
CC       ECO:0000269|PubMed:20525693}.
CC   -!- FUNCTION: Isoform 1, isoform 2, isoform 3 and isoform 4 stimulate
CC       the activity of SLC12A1, SLC12A2 and SLC12A3 and inhibit the
CC       activity of SLC12A4, SLC12A5, SLC12A6 and SLC12A7. According to
CC       PubMed:19470686, isoform 1 inhibits the activity of SLC12A3.
CC       {ECO:0000269|PubMed:19470686, ECO:0000269|PubMed:21613606}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:Q9H4A3};
CC   -!- ENZYME REGULATION: Activation requires autophosphorylation of Ser-
CC       308. Phosphorylation of Ser-304 also promotes increased activity
CC       (By similarity). Kinase activity is inhibited by WNK4.
CC       {ECO:0000250, ECO:0000269|PubMed:17975670}.
CC   -!- SUBUNIT: Interacts with WNK1 and WNK4.
CC       {ECO:0000269|PubMed:17975670}.
CC   -!- INTERACTION:
CC       P42574:CASP3; NbExp=2; IntAct=EBI-1182602, EBI-524064;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16501604}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9BYP7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BYP7-2; Sequence=VSP_041933;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q9BYP7-3; Sequence=VSP_041932, VSP_041933;
CC       Name=4;
CC         IsoId=Q9BYP7-4; Sequence=VSP_041932;
CC   -!- TISSUE SPECIFICITY: Expressed in brain, lung, kidney, liver and
CC       pancreas, and in fetal tissues including placenta, fetal brain,
CC       lung and kidney. Very low levels of expression were also detected
CC       in fetal heart, thymus, liver and spleen. Isoform 1 is brain-
CC       specific. Isoform 3 is kidney-specific.
CC       {ECO:0000269|PubMed:11571656, ECO:0000269|PubMed:15194194,
CC       ECO:0000269|PubMed:16275913}.
CC   -!- PTM: Ubiquitinated by the BCR(KLHL2) complex, leading to its
CC       degradation. {ECO:0000269|PubMed:23838290}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family. WNK subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -!- CAUTION: Cys-176 is present instead of the conserved Lys which is
CC       expected to be an active site residue. Lys-159 appears to fulfill
CC       the required catalytic function. {ECO:0000250|UniProtKB:Q9JIH7}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ409088; CAC32455.2; -; mRNA.
DR   EMBL; AY082340; AAL99253.1; -; mRNA.
DR   EMBL; AY352048; AAR89465.1; -; mRNA.
DR   EMBL; AL591766; CAI40707.1; -; Genomic_DNA.
DR   EMBL; AL049793; CAI40707.1; JOINED; Genomic_DNA.
DR   EMBL; Z84469; CAI40707.1; JOINED; Genomic_DNA.
DR   EMBL; Z84469; CAI42732.1; -; Genomic_DNA.
DR   EMBL; AL049793; CAI42732.1; JOINED; Genomic_DNA.
DR   EMBL; AL591766; CAI42732.1; JOINED; Genomic_DNA.
DR   EMBL; AL049793; CAI43128.1; -; Genomic_DNA.
DR   EMBL; AL591766; CAI43128.1; JOINED; Genomic_DNA.
DR   EMBL; Z84469; CAI43128.1; JOINED; Genomic_DNA.
DR   EMBL; AL591766; CAI40708.1; -; Genomic_DNA.
DR   EMBL; AL049793; CAI40708.1; JOINED; Genomic_DNA.
DR   EMBL; Z84469; CAI40708.1; JOINED; Genomic_DNA.
DR   EMBL; Z84469; CAI42733.1; -; Genomic_DNA.
DR   EMBL; AL049793; CAI42733.1; JOINED; Genomic_DNA.
DR   EMBL; AL591766; CAI42733.1; JOINED; Genomic_DNA.
DR   EMBL; AL049793; CAI43129.1; -; Genomic_DNA.
DR   EMBL; AL591766; CAI43129.1; JOINED; Genomic_DNA.
DR   EMBL; Z84469; CAI43129.1; JOINED; Genomic_DNA.
DR   EMBL; AB046786; BAB13392.1; -; mRNA.
DR   CCDS; CCDS14357.1; -. [Q9BYP7-1]
DR   CCDS; CCDS35302.1; -. [Q9BYP7-3]
DR   RefSeq; NP_001002838.1; NM_001002838.3. [Q9BYP7-3]
DR   RefSeq; NP_065973.2; NM_020922.4. [Q9BYP7-1]
DR   RefSeq; XP_006724656.1; XM_006724593.3. [Q9BYP7-3]
DR   RefSeq; XP_011529104.1; XM_011530802.2. [Q9BYP7-4]
DR   RefSeq; XP_016885230.1; XM_017029741.1. [Q9BYP7-1]
DR   RefSeq; XP_016885231.1; XM_017029742.1. [Q9BYP7-1]
DR   RefSeq; XP_016885232.1; XM_017029743.1. [Q9BYP7-1]
DR   RefSeq; XP_016885233.1; XM_017029744.1. [Q9BYP7-1]
DR   RefSeq; XP_016885234.1; XM_017029745.1. [Q9BYP7-2]
DR   UniGene; Hs.92423; -.
DR   ProteinModelPortal; Q9BYP7; -.
DR   SMR; Q9BYP7; -.
DR   BioGrid; 122422; 6.
DR   IntAct; Q9BYP7; 2.
DR   STRING; 9606.ENSP00000346667; -.
DR   BindingDB; Q9BYP7; -.
DR   ChEMBL; CHEMBL6055; -.
DR   GuidetoPHARMACOLOGY; 2282; -.
DR   iPTMnet; Q9BYP7; -.
DR   PhosphoSitePlus; Q9BYP7; -.
DR   BioMuta; WNK3; -.
DR   DMDM; 353526307; -.
DR   EPD; Q9BYP7; -.
DR   MaxQB; Q9BYP7; -.
DR   PaxDb; Q9BYP7; -.
DR   PeptideAtlas; Q9BYP7; -.
DR   PRIDE; Q9BYP7; -.
DR   Ensembl; ENST00000354646; ENSP00000346667; ENSG00000196632. [Q9BYP7-1]
DR   Ensembl; ENST00000375159; ENSP00000364301; ENSG00000196632. [Q9BYP7-1]
DR   Ensembl; ENST00000375169; ENSP00000364312; ENSG00000196632. [Q9BYP7-3]
DR   GeneID; 65267; -.
DR   KEGG; hsa:65267; -.
DR   UCSC; uc004dtc.3; human. [Q9BYP7-1]
DR   CTD; 65267; -.
DR   DisGeNET; 65267; -.
DR   GeneCards; WNK3; -.
DR   HGNC; HGNC:14543; WNK3.
DR   HPA; HPA077678; -.
DR   MIM; 300358; gene.
DR   neXtProt; NX_Q9BYP7; -.
DR   OpenTargets; ENSG00000196632; -.
DR   PharmGKB; PA33784; -.
DR   eggNOG; KOG0584; Eukaryota.
DR   eggNOG; ENOG410XQWZ; LUCA.
DR   GeneTree; ENSGT00800000124049; -.
DR   HOGENOM; HOG000049042; -.
DR   HOVERGEN; HBG050346; -.
DR   InParanoid; Q9BYP7; -.
DR   KO; K08867; -.
DR   OMA; SKDCFKE; -.
DR   OrthoDB; EOG091G06LL; -.
DR   PhylomeDB; Q9BYP7; -.
DR   TreeFam; TF315363; -.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   SignaLink; Q9BYP7; -.
DR   GeneWiki; WNK3; -.
DR   GenomeRNAi; 65267; -.
DR   PRO; PR:Q9BYP7; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000196632; -.
DR   CleanEx; HS_WNK3; -.
DR   ExpressionAtlas; Q9BYP7; baseline and differential.
DR   Genevisible; Q9BYP7; HS.
DR   GO; GO:0005912; C:adherens junction; ISS:BHF-UCL.
DR   GO; GO:0005923; C:bicellular tight junction; ISS:BHF-UCL.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; ISS:UniProtKB.
DR   GO; GO:0019869; F:chloride channel inhibitor activity; IDA:UniProtKB.
DR   GO; GO:0004672; F:protein kinase activity; IDA:BHF-UCL.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; ISS:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:0090188; P:negative regulation of pancreatic juice secretion; IEA:Ensembl.
DR   GO; GO:0051928; P:positive regulation of calcium ion transport; IMP:UniProtKB.
DR   GO; GO:0090004; P:positive regulation of establishment of protein localization to plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0032414; P:positive regulation of ion transmembrane transporter activity; IDA:BHF-UCL.
DR   GO; GO:0010800; P:positive regulation of peptidyl-threonine phosphorylation; IDA:UniProtKB.
DR   GO; GO:2000688; P:positive regulation of rubidium ion transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:2000682; P:positive regulation of rubidium ion transport; IDA:UniProtKB.
DR   GO; GO:2000651; P:positive regulation of sodium ion transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0010765; P:positive regulation of sodium ion transport; IDA:BHF-UCL.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:BHF-UCL.
DR   GO; GO:0006468; P:protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:0072661; P:protein targeting to plasma membrane; IMP:UniProtKB.
DR   GO; GO:0090279; P:regulation of calcium ion import; IMP:UniProtKB.
DR   GO; GO:2000021; P:regulation of ion homeostasis; IMP:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR024678; Kinase_OSR1/WNK_CCT.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF12202; OSR1_C; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Cytoplasm;
KW   Kinase; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase;
KW   Ubl conjugation.
FT   CHAIN         1   1800       Serine/threonine-protein kinase WNK3.
FT                                /FTId=PRO_0000086823.
FT   DOMAIN      147    405       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     153    161       ATP. {ECO:0000250|UniProtKB:Q8TDX7,
FT                                ECO:0000255|PROSITE-ProRule:PRU00159}.
FT   ACT_SITE    275    275       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     159    159       ATP. {ECO:0000250|UniProtKB:Q9JIH7,
FT                                ECO:0000255|PROSITE-ProRule:PRU00159}.
FT   MOD_RES      62     62       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     304    304       Phosphoserine; by autocatalysis.
FT                                {ECO:0000250}.
FT   MOD_RES     308    308       Phosphoserine; by autocatalysis.
FT                                {ECO:0000250}.
FT   MOD_RES    1070   1070       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q80XP9}.
FT   MOD_RES    1585   1585       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q80XP9}.
FT   MOD_RES    1638   1638       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ    1248   1294       Missing (in isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:10997877,
FT                                ECO:0000303|PubMed:11571656}.
FT                                /FTId=VSP_041932.
FT   VAR_SEQ    1614   1624       GKSCLINELEN -> D (in isoform 3 and
FT                                isoform 2). {ECO:0000303|PubMed:10997877,
FT                                ECO:0000303|PubMed:11571656}.
FT                                /FTId=VSP_041933.
FT   VARIANT     704    704       Q -> H (in dbSNP:rs56077971).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041323.
FT   VARIANT     854    854       S -> C (in a lung squamous cell carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041324.
FT   VARIANT     998    998       A -> T (in dbSNP:rs56404148).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041325.
FT   VARIANT    1169   1169       K -> E (in dbSNP:rs55903619).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041326.
FT   VARIANT    1375   1375       T -> I (in dbSNP:rs55879434).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041327.
FT   VARIANT    1533   1533       L -> F (in a lung large cell carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041328.
FT   VARIANT    1634   1634       S -> P (in a renal clear cell carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041329.
FT   MUTAGEN     294    294       D->A: Catalytically inactive form.
FT                                Inhibits sodium-coupled chloride
FT                                cotransporters and activates potassium-
FT                                coupled chloride cotransporters.
FT                                {ECO:0000269|PubMed:16275913,
FT                                ECO:0000269|PubMed:21613606}.
FT   CONFLICT     10     10       S -> N (in Ref. 3; AAL99253).
FT                                {ECO:0000305}.
FT   CONFLICT    431    432       WV -> RD (in Ref. 5; BAB13392).
FT                                {ECO:0000305}.
FT   CONFLICT   1211   1211       P -> S (in Ref. 5; BAB13392).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1800 AA;  198416 MW;  1766D6AC8C7DE864 CRC64;
     MATDSGDPAS TEDSEKPDGI SFENRVPQVA ATLTVEARLK EKNSTFSASG ETVERKRFFR
     KSVEMTEDDK VAESSPKDER IKAAMNIPRV DKLPSNVLRG GQEVKYEQCS KSTSEISKDC
     FKEKNEKEME EEAEMKAVAT SPSGRFLKFD IELGRGAFKT VYKGLDTETW VEVAWCELQD
     RKLTKAEQQR FKEEAEMLKG LQHPNIVRFY DSWESILKGK KCIVLVTELM TSGTLKTYLK
     RFKVMKPKVL RSWCRQILKG LQFLHTRTPP IIHRDLKCDN IFITGPTGSV KIGDLGLATL
     MRTSFAKSVI GTPEFMAPEM YEEHYDESVD VYAFGMCMLE MATSEYPYSE CQNAAQIYRK
     VTSGIKPASF NKVTDPEVKE IIEGCIRQNK SERLSIRDLL NHAFFAEDTG LRVELAEEDD
     CSNSSLALRL WVEDPKKLKG KHKDNEAIEF SFNLETDTPE EVAYEMVKSG FFHESDSKAV
     AKSIRDRVTP IKKTREKKPA GCLEERRDSQ CKSMGNVFPQ PQNTTLPLAP AQQTGAECEE
     TEVDQHVRQQ LLQRKPQQHC SSVTGDNLSE AGAASVIHSD TSSQPSVAYS SNQTMGSQMV
     SNIPQAEVNV PGQIYSSQQL VGHYQQVSGL QKHSKLTQPQ ILPLVQGQST VLPVHVLGPT
     VVSQPQVSPL TVQKVPQIKP VSQPVGAEQQ AALLKPDLVR SLNQDVATTK ENVSSPDNPS
     GNGKQDRIKQ RRASCPRPEK GTKFQLTVLQ VSTSGDNMVE CQLETHNNKM VTFKFDVDGD
     APEDIADYMV EDNFVLESEK EKFVEELRAI VGQAQEILHV HFATERATGV DSITVDSNSS
     QTGSSEQVQI NSTSTQTSNE SAPQSSPVGR WRFCINQTIR NRETQSPPSL QHSMSAVPGR
     HPLPSPKNTS NKEISRDTLL TIENNPCHRA LFTSKSEHKD VVDGKISECA SVETKQPAIL
     YQVEDNRQIM APVTNSSSYS TTSVRAVPAE CEGLTKQASI FIPVYPCHQT ASQADALMSH
     PGESTQTSGN SLTTLAFDQK PQTLSVQQPA MDAEFISQEG ETTVNTEASS PKTVIPTQTP
     GLEPTTLQPT TVLESDGERP PKLEFADNRI KTLDEKLRNL LYQEHSISSI YPESQKDTQS
     IDSPFSSSAE DTLSCPVTEV IAISHCGIKD SPVQSPNFQQ TGSKLLSNVA ASQPANISVF
     KRDLNVITSV PSELCLHEMS SDASLPGDPE AYPAAVSSGG AIHLQTGGGY FGLSFTCPSL
     KNPISKKSWT RKLKSWAYRL RQSTSFFKRS KVRQVETEEM RSAIAPDPIP LTRESTADTR
     ALNRCKAMSG SFQRGRFQVI TIPQQQSAKM TSFGIEHISV FSETNHSSEE AFIKTAKSQL
     VEIEPATQNP KTSFSYEKLQ ALQETCKENK GVPKQGDNFL SFSAACETDV SSVTPEKEFE
     ETSATGSSMQ SGSELLLKER EILTAGKQPS SDSEFSASLA GSGKSVAKTG PESNQCLPHH
     EEQAYAQTQS SLFYSPSSPM SSDDESEIED EDLKVELQRL REKHIQEVVN LQTQQNKELQ
     ELYERLRSIK DSKTQSTEIP LPPASPRRPR SFKSKLRSRP QSLTHVDNGI VATGKSCLIN
     ELENPLCVES NAASCQQSPA SKKGMFTDDL HKLVDDWTKE AVGNSLIKPS LNQLKQSQHK
     LETENWNKVS ENTPSTMGYT STWISSLSQI RGAVPTSLPQ GLSLPSFPGP LSSYGMPHVC
     QYNAVAGAGY PVQWVGISGT TQQSVVIPAQ SGGPFQPGMN MQAFPTSSVQ NPATIPPGPK
//
